CA9 and cancer: We assigned this excellent potency against purified CA IX and CA XII isozymes and the consistent and significant cancer cell killing obtained with PEGylated CAI 23 to the cooperative binding and bivalent association of this type of two-pronged inhibitor with the two neighboring active sites [70], as shown by Whitesides [71].